Cargando…
Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
The global burden of type 2 diabetes is estimated to currently affect over 350 million people worldwide and is anticipated to continue increasing over the next 20 years. Current treatment guidelines recommend the choice of pharmacotherapy based upon patient-specific parameters, with combination ther...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820208/ https://www.ncbi.nlm.nih.gov/pubmed/27099505 http://dx.doi.org/10.2147/TCRM.S73579 |